399 related articles for article (PubMed ID: 21949739)
1. The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min/+) mouse.
White JP; Baynes JW; Welle SL; Kostek MC; Matesic LE; Sato S; Carson JA
PLoS One; 2011; 6(9):e24650. PubMed ID: 21949739
[TBL] [Abstract][Full Text] [Related]
2. Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK.
White JP; Puppa MJ; Gao S; Sato S; Welle SL; Carson JA
Am J Physiol Endocrinol Metab; 2013 May; 304(10):E1042-52. PubMed ID: 23531613
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in the relationship of IL-6 signaling to cancer cachexia progression.
Hetzler KL; Hardee JP; Puppa MJ; Narsale AA; Sato S; Davis JM; Carson JA
Biochim Biophys Acta; 2015 May; 1852(5):816-25. PubMed ID: 25555992
[TBL] [Abstract][Full Text] [Related]
4. Altered cardiac muscle mTOR regulation during the progression of cancer cachexia in the ApcMin/+ mouse.
Manne ND; Lima M; Enos RT; Wehner P; Carson JA; Blough E
Int J Oncol; 2013 Jun; 42(6):2134-40. PubMed ID: 23589074
[TBL] [Abstract][Full Text] [Related]
5. Wheel running improves fasting-induced AMPK signaling in skeletal muscle from tumor-bearing mice.
Fix DK; Counts BR; Smuder AJ; Sarzynski MA; Koh HJ; Carson JA
Physiol Rep; 2021 Jul; 9(14):e14924. PubMed ID: 34270178
[TBL] [Abstract][Full Text] [Related]
6. High-Frequency Stimulation on Skeletal Muscle Maintenance in Female Cachectic Mice.
Sato S; Gao S; Puppa MJ; Kostek MC; Wilson LB; Carson JA
Med Sci Sports Exerc; 2019 Sep; 51(9):1828-1837. PubMed ID: 30933004
[TBL] [Abstract][Full Text] [Related]
7. Testosterone regulation of Akt/mTORC1/FoxO3a signaling in skeletal muscle.
White JP; Gao S; Puppa MJ; Sato S; Welle SL; Carson JA
Mol Cell Endocrinol; 2013 Jan; 365(2):174-86. PubMed ID: 23116773
[TBL] [Abstract][Full Text] [Related]
8. Muscle oxidative capacity during IL-6-dependent cancer cachexia.
White JP; Baltgalvis KA; Puppa MJ; Sato S; Baynes JW; Carson JA
Am J Physiol Regul Integr Comp Physiol; 2011 Feb; 300(2):R201-11. PubMed ID: 21148472
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 and cachexia in ApcMin/+ mice.
Baltgalvis KA; Berger FG; Pena MM; Davis JM; Muga SJ; Carson JA
Am J Physiol Regul Integr Comp Physiol; 2008 Feb; 294(2):R393-401. PubMed ID: 18056981
[TBL] [Abstract][Full Text] [Related]
10. Muscle wasting and interleukin-6-induced atrogin-I expression in the cachectic Apc ( Min/+ ) mouse.
Baltgalvis KA; Berger FG; Peña MM; Davis JM; White JP; Carson JA
Pflugers Arch; 2009 Mar; 457(5):989-1001. PubMed ID: 18712412
[TBL] [Abstract][Full Text] [Related]
11. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes.
Tong JF; Yan X; Zhu MJ; Du M
J Cell Biochem; 2009 Oct; 108(2):458-68. PubMed ID: 19639604
[TBL] [Abstract][Full Text] [Related]
12. Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting.
Song YH; Li Y; Du J; Mitch WE; Rosenthal N; Delafontaine P
J Clin Invest; 2005 Feb; 115(2):451-8. PubMed ID: 15650772
[TBL] [Abstract][Full Text] [Related]
13. Skeletal muscle protein balance in mTOR heterozygous mice in response to inflammation and leucine.
Lang CH; Frost RA; Bronson SK; Lynch CJ; Vary TC
Am J Physiol Endocrinol Metab; 2010 Jun; 298(6):E1283-94. PubMed ID: 20388826
[TBL] [Abstract][Full Text] [Related]
14. JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.
Bonetto A; Aydogdu T; Jin X; Zhang Z; Zhan R; Puzis L; Koniaris LG; Zimmers TA
Am J Physiol Endocrinol Metab; 2012 Aug; 303(3):E410-21. PubMed ID: 22669242
[TBL] [Abstract][Full Text] [Related]
15. Eccentric contraction-induced myofiber growth in tumor-bearing mice.
Hardee JP; Mangum JE; Gao S; Sato S; Hetzler KL; Puppa MJ; Fix DK; Carson JA
J Appl Physiol (1985); 2016 Jan; 120(1):29-37. PubMed ID: 26494443
[TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle function during the progression of cancer cachexia in the male Apc
VanderVeen BN; Hardee JP; Fix DK; Carson JA
J Appl Physiol (1985); 2018 Mar; 124(3):684-695. PubMed ID: 29122966
[TBL] [Abstract][Full Text] [Related]
17. Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype.
Chacon-Cabrera A; Mateu-Jimenez M; Langohr K; Fermoselle C; García-Arumí E; Andreu AL; Yelamos J; Barreiro E
J Cell Physiol; 2017 Dec; 232(12):3744-3761. PubMed ID: 28177129
[TBL] [Abstract][Full Text] [Related]
18. Development of an UPLC mass spectrometry method for measurement of myofibrillar protein synthesis: application to analysis of murine muscles during cancer cachexia.
Lima M; Sato S; Enos RT; Baynes JW; Carson JA
J Appl Physiol (1985); 2013 Mar; 114(6):824-8. PubMed ID: 23329823
[TBL] [Abstract][Full Text] [Related]
19. Activity level, apoptosis, and development of cachexia in Apc(Min/+) mice.
Baltgalvis KA; Berger FG; Peña MM; Mark Davis J; White JP; Carson JA
J Appl Physiol (1985); 2010 Oct; 109(4):1155-61. PubMed ID: 20651218
[TBL] [Abstract][Full Text] [Related]
20. Quercetin supplementation attenuates the progression of cancer cachexia in ApcMin/+ mice.
Velázquez KT; Enos RT; Narsale AA; Puppa MJ; Davis JM; Murphy EA; Carson JA
J Nutr; 2014 Jun; 144(6):868-75. PubMed ID: 24759931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
